LISTING PROSPECTUS / SHAREHOLDERS' CIRCULARS
TELIX PHARMACEUTICALS LIMITED
Prospectus
24 Jul 2024
A$650,000,000 2.375 per cent. Senior Unsecured Convertible Notes due 2029
Description:
A$650,000,000 2.375 PER CENT. SENIOR UNSECURED CONVERTIBLE NOTES DUE 2029
Attached document:
Telix Pharmaceuticals Limited issuance of A$650m 2.375 percent Senior Unsecured Convertible Notes due 2029_Offering Circular dated 24 July 2024.pdf
2.98 MB